Manuela González-Aparicio

914 total citations
24 papers, 645 citations indexed

About

Manuela González-Aparicio is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Manuela González-Aparicio has authored 24 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Manuela González-Aparicio's work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Manuela González-Aparicio is often cited by papers focused on Virus-based gene therapy research (12 papers), CAR-T cell therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Manuela González-Aparicio collaborates with scholars based in Spain, Israel and United States. Manuela González-Aparicio's co-authors include Rubén Hernández-Alcoceba, Carlos Alfaro, Ana Ricobaraza, Sara Lumbreras, Jesús Prìeto, María Buñuales, Gloria González‐Aseguinolaza, Pilar Alzuguren, Julien Crettaz and Itsaso Mauleón and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Hepatology.

In The Last Decade

Manuela González-Aparicio

24 papers receiving 635 citations

Peers

Countries citing papers authored by Manuela González-Aparicio

Since Specialization

Citations

This map shows the geographic impact of Manuela González-Aparicio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela González-Aparicio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela González-Aparicio more than expected).

Fields of papers citing papers by Manuela González-Aparicio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela González-Aparicio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela González-Aparicio. The network helps show where Manuela González-Aparicio may publish in the future.

Co-authorship network of co-authors of Manuela González-Aparicio

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela González-Aparicio. A scholar is included among the top collaborators of Manuela González-Aparicio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela González-Aparicio. Manuela González-Aparicio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles 2024 ·Gene Therapy ·María Buñuales, (unknown), Miguel Chillón, Assumpció Bosch, Manuela González-Aparicio, María Espelosin, (unknown), Alberto J. Rico, Ana Garcı́a-Osta, Mar Cuadrado‐Tejedor, José L. Lanciego, Rubén Hernández-Alcoceba	7
2	Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome 2023 ·Journal of Molecular Medicine ·Ana Ricobaraza, María Buñuales, Manuela González-Aparicio, (unknown), Moran Rubinstein, (unknown), (unknown), (unknown), Rocío Sánchez‐Carpintero, José L. Lanciego, Elvira Roda, (unknown), (unknown), Rubén Hernández-Alcoceba	6
3	Application of a split‐Cre system for high‐capacity adenoviral vector amplification 2022 ·Biotechnology Journal ·Manuela González-Aparicio, María Buñuales, (unknown), Jesús Prìeto, Rubén Hernández-Alcoceba	4
4	Gene supplementation of CYP27A1 in the liver restores bile acid metabolism in a mouse model of cerebrotendinous xanthomatosis 2021 ·Molecular Therapy — Methods & Clinical Development ·Sara Lumbreras, Ana Ricobaraza, Lucía Baila-Rueda, Manuela González-Aparicio, (unknown), Iker Uriarte, María Buñuales, Matías A. Ávila, María J. Monte, José J.G. Marı́n, Ana Cenarro, Gloria González‐Aseguinolaza, Rubén Hernández-Alcoceba	11
5	Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations 2021 ·Molecular Therapy — Nucleic Acids ·(unknown), Miguel Valencia, Rocío Sánchez‐Carpintero, Jan Tønnesen, (unknown), Moran Rubinstein, Manuela González-Aparicio, María Buñuales, (unknown), María Jesús Nicolás, Elena Puerta, Cristina Miguélez, (unknown), Sara Lumbreras, Gloria González‐Aseguinolaza, Ana Ricobaraza, Rubén Hernández-Alcoceba	28
6	Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis 2021 ·International Journal of Molecular Sciences ·María Buñuales, (unknown), Manuela González-Aparicio, Sandra Hervás‐Stubbs, Eva Martišová, Uxua Mancheño, Ana Ricobaraza, Sara Lumbreras, Cristian Smerdou, Rubén Hernández-Alcoceba	8
7	Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma 2020 ·Molecular Therapy — Oncolytics ·Marta Zalacaín, María Buñuales, Lucía Marrodán, Sara Labiano, Marisol González-Huarriz, Naiara Martínez-Vélez, Virginia Laspidea, Montse Puigdelloses, Marc García-Moure, Manuela González-Aparicio, Rubén Hernández-Alcoceba, Marta M. Alonso, Ana Patiño‐García	6
8	Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation 2019 ·Scientific Reports ·Ana Ricobaraza, (unknown), Elena Puerta, Rocío Sánchez‐Carpintero, Ana Mingorance, Julio Artieda, María Jesús Nicolás, (unknown), María Buñuales, Manuela González-Aparicio, (unknown), Miguel Valencia, Rubén Hernández-Alcoceba	53
9	Danio Rerio as Model Organism for Adenoviral Vector Evaluation 2019 ·Genes ·(unknown), Jorge Guerra‐Varela, Manuela González-Aparicio, Ana Ricobaraza, África Vales, Gloria González‐Aseguinolaza, Rubén Hernández-Alcoceba, Laura Sánchez	7
10	Inhibition of adenovirus infection by mifepristone 2018 ·Antiviral Research ·(unknown), Ana Serna‐Gallego, (unknown), María Buñuales, Joanna Poutou, Jerónimo Pachón, Manuela González-Aparicio, Rubén Hernández-Alcoceba, Javier Sánchez‐Céspedes	20
11	The role of IL-8 in the immune response associated to cancer development 2018 ·Manuela González-Aparicio, Carlos Alfaro	1
12	X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver 2017 ·Gastroenterology ·Josepmaria Argemí, Theresia R. Kress, (unknown), (unknown), Cristina Bértolo, Haritz Moreno, Manuela González-Aparicio, Iker Uriarte, Laura Guembe, Víctor Segura, Rubén Hernández-Alcoceba, Matías A. Ávila, Bruno Amati, Jesús Prìeto, Tomás Aragón	41
13	Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment 2017 ·Journal of Controlled Release ·Joanna Poutou, María Buñuales, Manuela González-Aparicio, (unknown), (unknown), Rubén Hernández-Alcoceba	9
14	Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model 2015 ·Molecular Cancer ·Estanislao Nistal‐Villán, María Buñuales, Joanna Poutou, Manuela González-Aparicio, Carlos Bravo‐Pérez, José I. Quetglas, (unknown), Gloria González‐Aseguinolaza, Jesús Prìeto, Esther Larrea, Rubén Hernández-Alcoceba	15
15	Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model 2015 ·Gene Therapy ·Joanna Poutou, María Buñuales, Manuela González-Aparicio, (unknown), José I. Quetglas, Raquel Bartolomé-Casado, Carlos Bravo‐Pérez, Pilar Alzuguren, Rubén Hernández-Alcoceba	36
16	Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice 2013 ·Human Molecular Genetics ·Carmen Unzu, Ana Sampedro, Itsaso Mauleón, Manuela González-Aparicio, Rafael Enrı́quez de Salamanca, Jesús Prìeto, Tomás Aragón, Antonio Fontanellas	18
17	Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B 2012 ·Hepatology ·Itziar Otano, (unknown), Javier Dotor, Manuela González-Aparicio, Julien Crettaz, Cristina Olagüe, (unknown), José Ignacio Riezu‐Boj, Esther Larrea, (unknown), Alberto Benito, Rubén Hernández-Alcoceba, Stephan Menne, Jesús Prìeto, Gloria González‐Aseguinolaza	18
18	Self-inactivating helper virus for the production of high-capacity adenoviral vectors 2011 ·Gene Therapy ·Manuela González-Aparicio, Itsaso Mauleón, Pilar Alzuguren, María Buñuales, Gloria González‐Aseguinolaza, Carmen San Martı́n, Jesús Prìeto, Rubén Hernández-Alcoceba	22
19	Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice 2010 ·Gut ·Manuela González-Aparicio, Pilar Alzuguren, Itsaso Mauleón, José Medina‐Echeverz, Sandra Hervás‐Stubbs, Uxua Mancheño, Pedro Berraondo, Julien Crettaz, Gloria González‐Aseguinolaza, Jesús Prìeto, Rubén Hernández-Alcoceba	88
20	Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy 2009 ·Molecular Cancer ·Maider Zabala, Pilar Alzuguren, (unknown), Julien Crettaz, Gloria González‐Aseguinolaza, Carlos Ortíz-de-Solórzano, Manuela González-Aparicio, M. Gabriela Kramer, Jesús Prìeto, Rubén Hernández-Alcoceba	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact